Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07761130
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke (iHeLP)Health Research Board, IrelandCompletedNot Applicable
NCT07761130Completed
Not Applicable
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke...Health Research Board, Ir...
NCT07760766
Auricular Acupressure for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic ChemotherapyChina Medical University, ChinaNot Yet RecruitingNot Applicable
NCT07760766Not Yet Recruiting
Not Applicable
Auricular Acupressure for Prevention of Chemotherapy-Induced Nausea and Vomiting...China Medical University,...
NCT07759778
Oliceridine-Propofol Dose for Gastroscope Insertion in Obese PatientsLu YiNot Yet RecruitingPhase 4
NCT07759778Not Yet Recruiting
Phase 4
Oliceridine-Propofol Dose for Gastroscope Insertion in Obese PatientsLu Yi
NCT07759297
Intraoperative Dexmedetomidine Use and Postoperative Delirium After Cardiac SurgeryShusheng LiCompleted
NCT07759297Completed
—
Intraoperative Dexmedetomidine Use and Postoperative Delirium After Cardiac Surg...Shusheng Li
NCT07760961
Effect of Mizagliflozin on Hypoglycemia in Patients With Post-Bariatric HypoglycemiaVogenx, Inc.Not Yet RecruitingPhase 2
NCT07760961Not Yet Recruiting
Phase 2
Effect of Mizagliflozin on Hypoglycemia in Patients With Post-Bariatric Hypoglyc...Vogenx, Inc.
NCT07760532
Comparing Facial Aging Between Identical Twins With 3D ImagingPonsky Facial Aesthetics And Plastic Surgery, LlcNot Yet Recruiting
NCT07760532Not Yet Recruiting
—
Comparing Facial Aging Between Identical Twins With 3D ImagingPonsky Facial Aesthetics...
NCT07761845
Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of Patients With Burn InjuriesAin Shams UniversityRecruiting
NCT07761845Recruiting
—
Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of...Ain Shams University
NCT07761026
The AXIS Registry is a 10-year Longitudinal Research Initiative That Captures the Real-world Experiences of People Living With Autoimmune Neurology Conditions. Launching in Myasthenia Gravis (MG), we Plan to Evaluate Expansion to Other Conditions Across Autoimmune Neurology.Alira HealthRecruiting
NCT07761026Recruiting
—
The AXIS Registry is a 10-year Longitudinal Research Initiative That Captures th...Alira Health
NCT07760831
A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative ColitisJiangsu HengRui Medicine Co., Ltd.Not Yet RecruitingPhase 1
NCT07760831Not Yet Recruiting
Phase 1
A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerativ...Jiangsu HengRui Medicine...
NCT07760090
Motor Imagery Added to Robot-Assisted Hand Rehabilitation After StrokeUskudar UniversityNot Yet RecruitingNot Applicable
NCT07760090Not Yet Recruiting
Not Applicable
Motor Imagery Added to Robot-Assisted Hand Rehabilitation After StrokeUskudar University
NCT07760636
Kinetics and Prognostic Value of NeuroFilament Light in Post-cardiac Arrest: A Prospective Multicenter StudyAssistance Publique - Hôpitaux de ParisNot Yet Recruiting
NCT07760636Not Yet Recruiting
—
Kinetics and Prognostic Value of NeuroFilament Light in Post-cardiac Arrest: A P...Assistance Publique - Hôp...
NCT07759375
Combined Intervention Program for Non-fluent Aphasia Based on NeuroplasticityUniversidad de GranadaNot Yet RecruitingNot Applicable
NCT07759375Not Yet Recruiting
Not Applicable
Combined Intervention Program for Non-fluent Aphasia Based on NeuroplasticityUniversidad de Granada
NCT07761650
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital LahoreCompletedNot Applicable
NCT07761650Completed
Not Applicable
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital Lahore
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07761325
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for Prevention of CINV in Breast Cancer Patients Receiving Highly Emetogenic ChemotherapySun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 3
NCT07761325Not Yet Recruiting
Phase 3
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone...Sun Yat-Sen Memorial Hosp...
NCT07759895
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in SchizophreniaAmit LotanNot Yet RecruitingPhase 2
NCT07759895Not Yet Recruiting
Phase 2
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Sy...Amit Lotan
NCT07759284
Endotracheal Tube Intolerance and Respiratory Airflow PerceptionPeking University People's HospitalNot Yet Recruiting
NCT07759284Not Yet Recruiting
—
Endotracheal Tube Intolerance and Respiratory Airflow PerceptionPeking University People'...
NCT07759726
Cellphone Access for Lowered Maternal Anxiety and Stress in Cesarean SectionsBeirut Arab UniversityCompletedNot Applicable
NCT07759726Completed
Not Applicable
Cellphone Access for Lowered Maternal Anxiety and Stress in Cesarean SectionsBeirut Arab University
NCT07760727
High-Flow Nasal Oxygyen Therapy During Sedated Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration(EBUS-TBNA)Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalNot Yet Recruiting
NCT07760727Not Yet Recruiting
—
High-Flow Nasal Oxygyen Therapy During Sedated Endobronchial Ultrasound-Guided T...Dr Abdurrahman Yurtaslan...
NCT07761806
Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile DysfunctionAin Shams UniversityCompletedPhase 2
NCT07761806Completed
Phase 2
Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile DysfunctionAin Shams University
Result Breakdown
Not yet recruiting13 (65%)
Completed5 (25%)
Recruiting2 (10%)
not_applicable7 (35%)
Not Specified7 (35%)
Phase 23 (15%)
Phase 41 (5%)
Phase 11 (5%)
Phase 31 (5%)